33
c
18
3b
14
10
32
43
19
Emily M. Ko
61 16
19
1
49
2
1c
1b
1d
18
29
72
1d
2 29
1d
25
Emily M. Ko
76
72
Associate Professor of Obstetrics and Gynecology at the Pennsylvania Hospital
28
a8
3
70
Attending, Gynecologic Oncology, Department of Obstetrics and Gynecology, Pennsylvania Hospital, Philadelphia, PA
bc
Attending, Gynecologic Oncology, Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania Philadelphia, PA
b5
Associate Fellowship Director, Division of Gynecologic Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
75
Medical Director, Pennsylvania Hospital Abramson Cancer Center
11
Department: Obstetrics and Gynecology
4
1
b
1d
46
Contact information
42
4
3
3
3
2
4
b
1f
42
Department of Ob/Gyn
28 Division of Gynecologic Oncology
30 University of Pennsylvania Health System
1d Pennsylvania Hospital
40 800 Walnut Street, 10th Floor
Philadelphia, PA 19107
26
28 Division of Gynecologic Oncology
30 University of Pennsylvania Health System
1d Pennsylvania Hospital
40 800 Walnut Street, 10th Floor
Philadelphia, PA 19107
2e
Office: 215-829-2345
32 Fax: 215-829-3365
24
f
32 Fax: 215-829-3365
24
13
Education:
21 9 A.B. 4a (Magna Cum Laude with Highest Honors in Cognitive Neuroscience) c
37 Harvard College, Cambridge, MA, 2000.
21 6 48 (American College of Pathology approved one-year fellowship.) c
52 University of Massachusetts Medical School, Worcester, MA, 2003.
21 7 MD 1e (Alpha Omega Alpha) c
52 University of Massachusetts Medical School, Worcester, MA, 2005.
21 9 MSCR 35 (Masters of Science in Clinical Research ) c
67 University of North Carolina Gillings School of Public Health, Chapel Hill, NC, 2013.
c
3
3
21
21 9 A.B. 4a (Magna Cum Laude with Highest Honors in Cognitive Neuroscience) c
37 Harvard College, Cambridge, MA, 2000.
21 6 48 (American College of Pathology approved one-year fellowship.) c
52 University of Massachusetts Medical School, Worcester, MA, 2003.
21 7 MD 1e (Alpha Omega Alpha) c
52 University of Massachusetts Medical School, Worcester, MA, 2005.
21 9 MSCR 35 (Masters of Science in Clinical Research ) c
67 University of North Carolina Gillings School of Public Health, Chapel Hill, NC, 2013.
c
1f
Post-Graduate Training
24 a6 Resident, Obstetrics and Gynecology, Brigham and Women’s Hospital and Massachusetts General Hospital/Harvard Medical School, Boston MA, 2005-2009.
24 69 Fellow, Gynecologic Oncology, University of North Carolina, Chapel Hill, NC, 2009-2012.
c
3
3
8d
Permanent link24 a6 Resident, Obstetrics and Gynecology, Brigham and Women’s Hospital and Massachusetts General Hospital/Harvard Medical School, Boston MA, 2005-2009.
24 69 Fellow, Gynecologic Oncology, University of North Carolina, Chapel Hill, NC, 2009-2012.
c
2 29
21
1e
1d
24
2b
29
27
23
f1 Ko EM, Muto MG, Berkowitz RS, Feltmate CM: Robotic versus open radical hysterectomy: a comparative study at a single institution. Gynecol Oncol 111(3):425-30, Dec 2008.
ff Semere LG, Ko E, Johnson NR, Vitonis AF, Phang LJ, Cramer DW, Mutter GL: Endometrial intraepithelial neoplasia clinical correlates and outcomes. Obstet Gynecol 118(1):21-8, Jul 2011.
133 Ko EM, Walter P, Jackson A, Clark L, Franasiak J, Bolac C, Havrilesky LaJ, Secord Angeles A, Moore DT, Gehrig PA, Bae-Jump V: Metformin is associated with improved survival in endometrial cancer. Gynecol Oncol 132(2):438-42, Nov 2013.
fb Ko EM, Stürmer T, Hong JL, Castillo WC, Bae-Jump V, Funk MJ: Metformin and the risk of endometrial cancer: A population-based cohort study. Gynecol Oncol 136(2):341-7, Feb 2015.
169 Ko EM, Walter P, Clark L, Jackson A, Franasiak J, Bolac C, Havrilesky L, Secord Angeles A, Moore DT, Gehrig PA, Bae-Jump VL: The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance. Gynecol Oncol 133(1):28-32, Apr 2014.
138 Haggerty A, Huepenbecker S, Sarwer D, Spitzer J, Raggio G, Chu C, Ko EM, Allison K: The use of novel technology-based weight loss interventions for obese women with endometrial hyperplasia and cancer. Gynecol Oncol 140(2):239-44, Feb 2016.
110 Clark LH, Jackson AL, Gehrig PA, Bae-Jump V, Van Le L, Ko EM: Adjuvant treatment and clinical trials in elderly with endometrial cancer: a time for change? Int J Gynecol Cancer 26(2):282-9, Feb 2016.
159 Graul A, Latif N, Zhang X, Dean LT, Morgan M, Giuntoli R, Burger R, Kim S, Ko E: Incidence of Venous Thromboembolism by Type of Gynecologic Malignancy and Surgical Modality in the National Surgical Quality Improvement Program. Int J Gynecol Cancer 27(3):581-587, Mar 2017.
12d Cory L, Latif N, Brensinger C, Zhang X, Giuntoli RL 2nd, Burger RA, Morgan M, Ko E: Readmission After Gynecologic Surgery: A Comparison of Procedures for Benign and Malignant Indications. Obstet Gynecol 130(2):285-295, Aug 2017.
158 Cohn DE, Ko E, Meyer LA, Wright JD, Temkin SM, Foote J, Jones NL, Havrilesky LJ: The "value" of value in gynecologic oncology practice in the United States: Society of Gynecologic Oncology evidence-based review and recommendations. Gynecol Oncol 145(1):185-191, Apr 2017.
103 Haggerty AF, Sarwer DB, Schmitz KH, Ko EM, Allison KC, Chu CS: Obesity and Endometrial Cancer: A Lack of Knowledge but Opportunity for Intervention. Nutr Cancer 69(7):990-995, Sept 2017.
173 Haggerty A, Hagemann A, Barnett M, Thornquist M, Neuhouser M, Horowitz N, Colditz G, Sarwer DB, Ko E, Allison KC: A Randomized Controlled, Multi-Center Study of Technology-Based Weight Loss Interventions Among Endometrial Cancer Survivors. Obesity. Silver Spring, 25 (Suppl 2): S102-S108, Nov 2017.
1af Ko EM, Havrilesky LJ, Alvarez RD, Zivanovic O, Boyd LR, Jewell EL, Timmins PF 3rd, Gibb RS, Jhingran A, Cohn DE, Dowdy SC, Powell MA, Chalas E, Huang Y, Rathbun J, Wright JD: Society of Gynecologic Oncology Future of Physician Payment Reform Task Force report: The Endometrial Cancer Alternative Payment Model (ECAP). Gynecol Oncol 149(2): 232-240, May 2018.
1c1 Wright JD, Havrilesky LJ, Cohn DE, Huang Y, Rathbun J, Rice LW, Brown CL, Alvarez RD, Ko EM: Estimating potential for savings for low risk endometrial cancer using the Endometrial Cancer Alternative Payment Model (ECAP): A companion paper to the Society of Gynecologic Oncology Report on the Endometrial Cancer Alternative Payment Model. Gynecol Oncol 149(2):241-47, May 2018.
14f Cory L, Cha B, Ellenberg S, Bogner HR, Hwang WT, Smith JS, Haggerty A, Morgan MA, Burger RA, Chu C, Ko EM: Effects of Educational Interventions on Human Papillomavirus Vaccine Acceptability: A Randomized Controlled Trial. Obstet Gynecol 134(2):376-384, Aug 2019.
14b Albright BB, Shorter J, Mastroyannis SA, Ko EM, Schreiber C, Sonalkar S: Gestational trophoblastic neoplasia after Human Chorionic Gonadotropin normalization following molar pregnancy: A systematic review and meta-analysis. Obstet Gyn 135(1):12-23, Jan 2020.
d0 Nasioudis D, Bhadra M, Ko EM: Extramammary Paget disease of the vulva: Management and Prognosis. Gynecol Oncol 157(1):146-15, Apr 2020.
199 Zamarin D, Burger RA, Sill MW, Powell DJ Jr, Lankes HA, Feldman MD, Zivanovic O, Gunderson C, Ko E, Mathews C, Sharma S, Hagemann AR, Khleif S, Aghajanian C: Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study. J Clin Oncol 38(16):1814-1823, Jun 2020.
f7 Washington CR, Haggerty A, Ronner W, Neff PM, Ko EM: Knowledge of Endometrial Cancer Risk Factors in a General Gynecologic Population. Gynecol Oncol 158(1):137-142, Jul 2020.
116 Spieker AJ, Ko EM, Roy JA, Mitra N: Nested g-computation: A causal approach to analysis of censored medical costs in the presence of time-varying treatment. J R Stat Soc Series C 69(5):1189-1208, Nov 2020.
165 Ko EM, Brensinger CM, Cory L, Giuntoli 2nd RL, Haggerty AF, Latif NA, Aviles D, Martin L, Morgan MA, Lin LL: Utilization and survival outcomes of sequential, concurrent and sandwich therapies for advanced stage endometrial cancers by histology. Gynecol Oncol 159(2):394-401, Nov 2020.
12d Latif N, Oh J, Brensinger C, Morgan M, Lin L, Cory L, Ko EM: Lymphadenectomy is Associated with an Increased Risk of Postoperative Venous Thromboembolism in Early Stage Endometrial Cancer. Gynecol Oncol 161(1):130-134, Apr 2021.
11e Aviki EM, Schleicher SM, Boyd L, Liang M, Ko EM, Zanotti K, Moss H: The oncology care model and the future of alternative payment models: A gynecologic oncology perspective. Gynecol Oncol 162(3):529-531, Sep 2021.
106 Ko EM, Bekelman JE, Hicks-Courant K, Brensinger CM, Kanter GP: Association of gynecologic oncology versus medical oncology specialty with survival, utilization, and spending for treatment of gynecologic cancers. 3f Gynecol Oncol 164(2):295-30, Feb 2022.
15d Saris DH, Bodurtha Smith AJ, Brensinger C, Kim SH, Haggerty AF, Latif N, Cory L, Giuntoli RL, Morgan MA, Lin LL, Ko EM: Disparities in Cancer-Specific and Overall Survival in Black Women with Endometrial Cancer: A Medicare-SEER Study. Gynecol Oncol Report 40:100922, Jan 2022.
cf Bodurtha Smith AJ, Pena D, Ko E: Insurance-Mediated Disparities in Gynecologic Oncology Care. Obstet Gynecol 139(2):305-312, Jan 2022.
f0 Hicks-Courant K, Kanter GP, Schapira MM, Brensinger CM, Liu Q, Ko EM: Intensity of end-of-life care for gynecologic cancer patients by primary oncologist specialty. Int J Gynecol Cancer 2d 32(6):695-703, Jun 2022.
10f Smith AJB, Mulugeta-Gordon L, Pena D, Kanter GP, Bekelman JE, Haggerty AE, Ko EM: Prior authorization in gynecologic oncology: An analysis of clinical impact. Gynecol Oncol 167(3):519-522, Dec 2022.
f3 Smith AJB, Alvarez R, Heintz J, Haggerty A, Ko EM: Disparities in biomarker testing in ovarian cancer: a real-world analysis. Am J Obstet Gynecol 228(1):98-100, Jan 2023.
2c
7
1d
1f
Selected Publications
d7 Ko E, Funk MJ, Clark L, Brewster W: Did GOG99 and Portec1 Change Clinical Practice in the United States? Gynecol Oncol 129(1):12-17, Apr 2013.f1 Ko EM, Muto MG, Berkowitz RS, Feltmate CM: Robotic versus open radical hysterectomy: a comparative study at a single institution. Gynecol Oncol 111(3):425-30, Dec 2008.
ff Semere LG, Ko E, Johnson NR, Vitonis AF, Phang LJ, Cramer DW, Mutter GL: Endometrial intraepithelial neoplasia clinical correlates and outcomes. Obstet Gynecol 118(1):21-8, Jul 2011.
133 Ko EM, Walter P, Jackson A, Clark L, Franasiak J, Bolac C, Havrilesky LaJ, Secord Angeles A, Moore DT, Gehrig PA, Bae-Jump V: Metformin is associated with improved survival in endometrial cancer. Gynecol Oncol 132(2):438-42, Nov 2013.
fb Ko EM, Stürmer T, Hong JL, Castillo WC, Bae-Jump V, Funk MJ: Metformin and the risk of endometrial cancer: A population-based cohort study. Gynecol Oncol 136(2):341-7, Feb 2015.
169 Ko EM, Walter P, Clark L, Jackson A, Franasiak J, Bolac C, Havrilesky L, Secord Angeles A, Moore DT, Gehrig PA, Bae-Jump VL: The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance. Gynecol Oncol 133(1):28-32, Apr 2014.
138 Haggerty A, Huepenbecker S, Sarwer D, Spitzer J, Raggio G, Chu C, Ko EM, Allison K: The use of novel technology-based weight loss interventions for obese women with endometrial hyperplasia and cancer. Gynecol Oncol 140(2):239-44, Feb 2016.
110 Clark LH, Jackson AL, Gehrig PA, Bae-Jump V, Van Le L, Ko EM: Adjuvant treatment and clinical trials in elderly with endometrial cancer: a time for change? Int J Gynecol Cancer 26(2):282-9, Feb 2016.
159 Graul A, Latif N, Zhang X, Dean LT, Morgan M, Giuntoli R, Burger R, Kim S, Ko E: Incidence of Venous Thromboembolism by Type of Gynecologic Malignancy and Surgical Modality in the National Surgical Quality Improvement Program. Int J Gynecol Cancer 27(3):581-587, Mar 2017.
12d Cory L, Latif N, Brensinger C, Zhang X, Giuntoli RL 2nd, Burger RA, Morgan M, Ko E: Readmission After Gynecologic Surgery: A Comparison of Procedures for Benign and Malignant Indications. Obstet Gynecol 130(2):285-295, Aug 2017.
158 Cohn DE, Ko E, Meyer LA, Wright JD, Temkin SM, Foote J, Jones NL, Havrilesky LJ: The "value" of value in gynecologic oncology practice in the United States: Society of Gynecologic Oncology evidence-based review and recommendations. Gynecol Oncol 145(1):185-191, Apr 2017.
103 Haggerty AF, Sarwer DB, Schmitz KH, Ko EM, Allison KC, Chu CS: Obesity and Endometrial Cancer: A Lack of Knowledge but Opportunity for Intervention. Nutr Cancer 69(7):990-995, Sept 2017.
173 Haggerty A, Hagemann A, Barnett M, Thornquist M, Neuhouser M, Horowitz N, Colditz G, Sarwer DB, Ko E, Allison KC: A Randomized Controlled, Multi-Center Study of Technology-Based Weight Loss Interventions Among Endometrial Cancer Survivors. Obesity. Silver Spring, 25 (Suppl 2): S102-S108, Nov 2017.
1af Ko EM, Havrilesky LJ, Alvarez RD, Zivanovic O, Boyd LR, Jewell EL, Timmins PF 3rd, Gibb RS, Jhingran A, Cohn DE, Dowdy SC, Powell MA, Chalas E, Huang Y, Rathbun J, Wright JD: Society of Gynecologic Oncology Future of Physician Payment Reform Task Force report: The Endometrial Cancer Alternative Payment Model (ECAP). Gynecol Oncol 149(2): 232-240, May 2018.
1c1 Wright JD, Havrilesky LJ, Cohn DE, Huang Y, Rathbun J, Rice LW, Brown CL, Alvarez RD, Ko EM: Estimating potential for savings for low risk endometrial cancer using the Endometrial Cancer Alternative Payment Model (ECAP): A companion paper to the Society of Gynecologic Oncology Report on the Endometrial Cancer Alternative Payment Model. Gynecol Oncol 149(2):241-47, May 2018.
14f Cory L, Cha B, Ellenberg S, Bogner HR, Hwang WT, Smith JS, Haggerty A, Morgan MA, Burger RA, Chu C, Ko EM: Effects of Educational Interventions on Human Papillomavirus Vaccine Acceptability: A Randomized Controlled Trial. Obstet Gynecol 134(2):376-384, Aug 2019.
14b Albright BB, Shorter J, Mastroyannis SA, Ko EM, Schreiber C, Sonalkar S: Gestational trophoblastic neoplasia after Human Chorionic Gonadotropin normalization following molar pregnancy: A systematic review and meta-analysis. Obstet Gyn 135(1):12-23, Jan 2020.
d0 Nasioudis D, Bhadra M, Ko EM: Extramammary Paget disease of the vulva: Management and Prognosis. Gynecol Oncol 157(1):146-15, Apr 2020.
199 Zamarin D, Burger RA, Sill MW, Powell DJ Jr, Lankes HA, Feldman MD, Zivanovic O, Gunderson C, Ko E, Mathews C, Sharma S, Hagemann AR, Khleif S, Aghajanian C: Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study. J Clin Oncol 38(16):1814-1823, Jun 2020.
f7 Washington CR, Haggerty A, Ronner W, Neff PM, Ko EM: Knowledge of Endometrial Cancer Risk Factors in a General Gynecologic Population. Gynecol Oncol 158(1):137-142, Jul 2020.
116 Spieker AJ, Ko EM, Roy JA, Mitra N: Nested g-computation: A causal approach to analysis of censored medical costs in the presence of time-varying treatment. J R Stat Soc Series C 69(5):1189-1208, Nov 2020.
165 Ko EM, Brensinger CM, Cory L, Giuntoli 2nd RL, Haggerty AF, Latif NA, Aviles D, Martin L, Morgan MA, Lin LL: Utilization and survival outcomes of sequential, concurrent and sandwich therapies for advanced stage endometrial cancers by histology. Gynecol Oncol 159(2):394-401, Nov 2020.
12d Latif N, Oh J, Brensinger C, Morgan M, Lin L, Cory L, Ko EM: Lymphadenectomy is Associated with an Increased Risk of Postoperative Venous Thromboembolism in Early Stage Endometrial Cancer. Gynecol Oncol 161(1):130-134, Apr 2021.
11e Aviki EM, Schleicher SM, Boyd L, Liang M, Ko EM, Zanotti K, Moss H: The oncology care model and the future of alternative payment models: A gynecologic oncology perspective. Gynecol Oncol 162(3):529-531, Sep 2021.
106 Ko EM, Bekelman JE, Hicks-Courant K, Brensinger CM, Kanter GP: Association of gynecologic oncology versus medical oncology specialty with survival, utilization, and spending for treatment of gynecologic cancers. 3f Gynecol Oncol 164(2):295-30, Feb 2022.
15d Saris DH, Bodurtha Smith AJ, Brensinger C, Kim SH, Haggerty AF, Latif N, Cory L, Giuntoli RL, Morgan MA, Lin LL, Ko EM: Disparities in Cancer-Specific and Overall Survival in Black Women with Endometrial Cancer: A Medicare-SEER Study. Gynecol Oncol Report 40:100922, Jan 2022.
cf Bodurtha Smith AJ, Pena D, Ko E: Insurance-Mediated Disparities in Gynecologic Oncology Care. Obstet Gynecol 139(2):305-312, Jan 2022.
f0 Hicks-Courant K, Kanter GP, Schapira MM, Brensinger CM, Liu Q, Ko EM: Intensity of end-of-life care for gynecologic cancer patients by primary oncologist specialty. Int J Gynecol Cancer 2d 32(6):695-703, Jun 2022.
10f Smith AJB, Mulugeta-Gordon L, Pena D, Kanter GP, Bekelman JE, Haggerty AE, Ko EM: Prior authorization in gynecologic oncology: An analysis of clinical impact. Gynecol Oncol 167(3):519-522, Dec 2022.
f3 Smith AJB, Alvarez R, Heintz J, Haggerty A, Ko EM: Disparities in biomarker testing in ovarian cancer: a real-world analysis. Am J Obstet Gynecol 228(1):98-100, Jan 2023.
2c